Aviv Regev Selected Research

Small Cytoplasmic RNA

11/2021	Identifying disease-critical cell types and cellular processes across the human body by integration of single-cell profiles and human genetics.
1/2021	Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma.
1/2021	Skin-resident innate lymphoid cells converge on a pathogenic effector state.
1/2020	A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
1/2019	A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia.
11/2018	A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
1/2018	Comprehensive Identification and Spatial Mapping of Habenular Neuronal Types Using Single-Cell RNA-Seq.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aviv Regev Research Topics

Disease

54	Neoplasms (Cancer) 10/2022 - 10/2004
11	Inflammation (Inflammations) 11/2022 - 10/2012
10	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 06/2014
7	Glioma (Gliomas) 10/2021 - 01/2017
6	Melanoma (Melanoma, Malignant) 01/2022 - 04/2016
5	Infections 03/2022 - 06/2012
5	Autoimmune Diseases (Autoimmune Disease) 12/2016 - 11/2011
4	Anemia 01/2022 - 11/2019
4	Adenocarcinoma of Lung 01/2022 - 12/2019
3	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2020
3	COVID-19 03/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2018 - 12/2009
2	Ulcerative Colitis 10/2022 - 11/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2022
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 08/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2019
2	Disease Progression 11/2021 - 01/2018
2	Adenocarcinoma 01/2021 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2016
2	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2017
2	Human Influenza (Influenza) 12/2018 - 03/2014
2	Pneumonia (Pneumonitis) 11/2017 - 01/2017
2	Leukemia 01/2017 - 04/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016 - 09/2014
2	Wounds and Injuries (Trauma) 12/2015 - 01/2008
1	Seizures (Absence Seizure) 11/2022
1	Reinfection 03/2022
1	Autism Spectrum Disorder 01/2022
1	Colitis 01/2022
1	idiopathic Aplastic anemia 01/2022
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2022
1	Polyps 12/2021
1	Major Depressive Disorder (Major Depressive Disorders) 11/2021
1	Multiple Sclerosis 11/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Residual Neoplasm 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021

Drug/Important Bio-Agent (IBA)

36	RNA (Ribonucleic Acid)IBA 11/2022 - 08/2013
7	Small Cytoplasmic RNAIBA 11/2021 - 01/2018
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 11/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2009
6	Immune Checkpoint InhibitorsIBA 10/2021 - 11/2018
5	InterferonsIBA 01/2022 - 03/2014
4	Biological ProductsIBA 01/2022 - 01/2020
4	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2004
3	AntigensIBA 08/2022 - 01/2021
3	ChromatinIBA 01/2022 - 01/2017
3	Interleukin-22 (IL-22)IBA 11/2021 - 01/2021
3	CytokinesIBA 01/2021 - 09/2014
3	Protein Isoforms (Isoforms)IBA 01/2021 - 12/2018
3	Estrogen ReceptorsIBA 11/2020 - 05/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2004
3	Interleukin-17 (Interleukin 17)IBA 12/2016 - 10/2012
2	Interleukin-33IBA 11/2022 - 12/2019
2	Hormones (Hormone)IBA 01/2022 - 01/2020
2	EpitopesIBA 01/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2022 - 10/2018
2	VaccinesIBA 01/2022 - 01/2019
2	Complement System Proteins (Complement)IBA 11/2021 - 06/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 10/2021 - 01/2019
2	T Cell Transcription Factor 1IBA 10/2021 - 01/2020
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2017
2	AndrogensIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2008
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 10/2012
2	Interleukin-27 (Interleukin 27)IBA 11/2020 - 01/2017
2	Fulvestrant (Faslodex)FDA Link 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2019
2	NeuropeptidesIBA 11/2017 - 01/2017
1	AutoantigensIBA 08/2022
1	Neutralizing AntibodiesIBA 03/2022
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	itacitinibIBA 01/2022
1	GATA1 Transcription FactorIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 12/2021
1	PlasticsIBA 10/2021
1	Viral RNAIBA 02/2021
1	Histamine Receptors (Histamine Receptor)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	PolyaminesIBA 01/2021
1	enzalutamideIBA 01/2021
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	InterleukinsIBA 01/2021
1	ChemokinesIBA 01/2021
1	AntioxidantsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	MucinsIBA 01/2021
1	Nizatidine (Axid)FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021

Therapy/Procedure

22	Therapeutics 08/2022 - 01/2008
10	Immunotherapy 10/2022 - 11/2018
1	Castration 01/2021